BALAJI AMINES Latest Share Price (BALAMINES)
TODAY IN ONE LINE
BALAMINES slipped 0.5% on light volume, lagging Nifty's 1.1% move.
With a market cap of ₹5,990.94 Cr., it trades at a P/E of 29.22. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
BALAJI AMINES flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 61.7% YoY
- ●Healthy Operating MarginsOPM is structurally strong at 16.7%
- ●High Promoter HoldingPromoters hold 54.6% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.06x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 7.9%
Latest BALAJI AMINES News
What changed recently?
Recent events, corporate actions, and announcements.
BALAJI AMINES valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for BALAJI AMINES, framed against the sector median so the premium or discount is obvious at a glance.
BALAJI AMINES trades at a P/E of 29.22× and P/B of 3.03×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
BALAJI AMINES technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for BALAJI AMINES — derived from the latest tape, not yesterday's close.
BALAJI AMINES last traded at ₹1,848.8 with an intraday range of ₹1,810.1–₹1,874.7 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1848.80| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 2008.17 | +159.37 | +8.62% |
| R3 | 1943.57 | +94.77 | +5.13% |
| R2 | 1909.13 | +60.33 | +3.26% |
| R1 | 1878.97 | +30.17 | +1.63% |
| PIVOT | 1844.53 | -4.27 | -0.23% |
| CURRENT | 1848.80 | — | — |
| S1 | 1814.37 | -34.43 | -1.86% |
| S2 | 1779.93 | -68.87 | -3.72% |
| S3 | 1749.77 | -99.03 | -5.36% |
| S4 | 1685.17 | -163.63 | -8.85% |
BALAMINES is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹1810.1–₹1874.7
Trading Inside opening range
BALAJI AMINES financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for BALAJI AMINES — consolidated or standalone — with margins, YoY growth and key ratios inline.
BALAJI AMINES reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹5,990.94 Cr. and reported EPS of ₹63.28.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 1,425 | 1,425 ▲ 0.0% |
| Sales Growth YoY %Derived | 2.00% | 2.00% |
| Other Income | 29 | 29 ▲ 0.0% |
| Total Income | 1,454 | 1,454 ▲ 0.0% |
| 796 | 796 ▲ 0.0% | |
| Gross ProfitDerived | 629 | 629 ▲ 0.0% |
| Gross Margin %Derived | 44.14% | 44.14% |
| 364 | 364 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 265 | 265 ▲ 0.0% |
| OPM %Derived | 18.63% | 18.63% |
| 62 | 62 ▲ 0.0% | |
| Profit Before Tax (PBT) | 232 | 232 ▲ 0.0% |
| 63 | 63 ▲ 0.0% | |
| Effective Tax %Derived | 27.24% | 27.24% |
| Total Profit for Period | 169 | 169 ▲ 0.0% |
| Less: Non-controlling Interests | — | — |
| Net Profit (Owner's PAT)Derived | 169 | 169 ▲ 0.0% |
| Net Profit Margin %Derived | 11.87% | 11.87% |
| PAT Growth YoY %Derived | 7.45% | 7.45% |
| Earnings Per Share (EPS ₹) | 52.21 | 52.21 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 1,221 | 1,221 ▲ 0.0% |
| Material Cost % of RevenueDerived | 56.92% | 56.92% |
| Employee Cost % of RevenueDerived | 5.90% | 5.90% |
| Other Cost % of RevenueDerived | 19.61% | 19.61% |
| Interest Coverage (x)Derived | 38.93x | 38.93x |
| Period | Mar 2018 | May 2018 | Mar 2019 | May 2019 | Mar 2020 | Jun 2020 | Mar 2021 | May 2021 | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 877 | 877 ▲ 0.0% | 943 ▲ 7.5% | 943 ▲ 0.0% | 936 ▼ 0.8% | 936 ▲ 0.0% | 1,311 ▲ 40.1% | 1,311 ▲ 0.0% | 2,320 ▲ 76.9% | 2,320 ▲ 0.0% | 2,355 ▲ 1.5% | 2,355 ▲ 0.0% | 1,642 ▼ 30.3% | 1,642 ▲ 0.0% | 1,397 ▼ 14.9% | 1,397 ▲ 0.0% | 1,425 ▲ 2.0% | 1,425 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | 7.53% | 7.53% | -0.77% | — | 40.15% | — | 76.93% | 76.93% | 1.51% | 1.51% | -30.31% | -30.31% | -14.89% | -14.89% | 2.00% | 2.00% | |
| Other Income | 4 | 4 ▲ 0.0% | 4 ▲ 4.2% | 4 ▲ 0.0% | 5 ▲ 18.6% | 5 ▲ 0.0% | 6 ▲ 21.1% | 6 ▲ 0.0% | 7 ▲ 19.3% | 7 ▲ 0.0% | 15 ▲ 110.4% | 15 ▲ 0.0% | 30 ▲ 94.4% | 30 ▲ 0.0% | 33 ▲ 12.0% | 33 ▲ 0.0% | 29 ▼ 13.2% | 29 ▲ 0.0% | |
| Total Income | 881 | 881 ▲ 0.0% | 947 ▲ 7.5% | 947 ▲ 0.0% | 941 ▼ 0.7% | 941 ▲ 0.0% | 1,318 ▲ 40.0% | 1,318 ▲ 0.0% | 2,328 ▲ 76.7% | 2,328 ▲ 0.0% | 2,371 ▲ 1.8% | 2,371 ▲ 0.0% | 1,671 ▼ 29.5% | 1,671 ▲ 0.0% | 1,430 ▼ 14.4% | 1,430 ▲ 0.0% | 1,454 ▲ 1.6% | 1,454 ▲ 0.0% | |
464 | 464 ▲ 0.0% | 515 ▲ 11.0% | 515 ▲ 0.0% | 514 ▼ 0.3% | 514 ▲ 0.0% | 630 ▲ 22.7% | 630 ▲ 0.0% | 1,223 ▲ 94.0% | 1,223 ▲ 0.0% | 1,246 ▲ 1.9% | 1,246 ▲ 0.0% | 903 ▼ 27.5% | 903 ▲ 0.0% | 781 ▼ 13.6% | 781 ▲ 0.0% | 796 ▲ 2.0% | 796 ▲ 0.0% | ||
| Gross ProfitDerived | 413 | 413 ▲ 0.0% | 428 ▲ 3.6% | 428 ▲ 0.0% | 422 ▼ 1.3% | 422 ▲ 0.0% | 681 ▲ 61.4% | 681 ▲ 0.0% | 1,098 ▲ 61.2% | 1,098 ▲ 0.0% | 1,110 ▲ 1.1% | 1,110 ▲ 0.0% | 738 ▼ 33.5% | 738 ▲ 0.0% | 616 ▼ 16.5% | 616 ▲ 0.0% | 629 ▲ 2.0% | 629 ▲ 0.0% | |
| Gross Margin %Derived | 47.08% | 47.08% | 45.35% | 45.35% | 45.09% | 45.09% | 51.94% | 51.94% | 47.31% | 47.31% | 47.11% | 47.11% | 44.98% | 44.98% | 44.12% | 44.12% | 44.14% | 44.14% | |
223 | 223 ▲ 0.0% | 234 ▲ 4.8% | 234 ▲ 0.0% | 241 ▲ 2.9% | 241 ▲ 0.0% | 308 ▲ 27.7% | 308 ▲ 0.0% | 468 ▲ 51.9% | 468 ▲ 0.0% | 500 ▲ 7.0% | 500 ▲ 0.0% | 415 ▼ 17.2% | 415 ▲ 0.0% | 384 ▼ 7.3% | 384 ▲ 0.0% | 364 ▼ 5.4% | 364 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 189 | 189 ▲ 0.0% | 193 ▲ 2.1% | 193 ▲ 0.0% | 181 ▼ 6.5% | 181 ▲ 0.0% | 373 ▲ 106.5% | 373 ▲ 0.0% | 630 ▲ 68.8% | 630 ▲ 0.0% | 609 ▼ 3.3% | 609 ▲ 0.0% | 324 ▼ 46.9% | 324 ▲ 0.0% | 232 ▼ 28.3% | 232 ▲ 0.0% | 265 ▲ 14.3% | 265 ▲ 0.0% | |
| OPM %Derived | 21.60% | 21.60% | 20.51% | 20.51% | 19.32% | 19.32% | 28.46% | 28.46% | 27.16% | 27.16% | 25.86% | 25.86% | 19.72% | 19.72% | 16.62% | 16.62% | 18.63% | 18.63% | |
29 | 29 ▲ 0.0% | 36 ▲ 24.9% | 36 ▲ 0.0% | 59 ▲ 63.3% | 59 ▲ 0.0% | 53 ▼ 10.7% | 53 ▲ 0.0% | 59 ▲ 12.1% | 59 ▲ 0.0% | 58 ▼ 2.6% | 58 ▲ 0.0% | 52 ▼ 10.0% | 52 ▲ 0.0% | 52 ▲ 0.6% | 52 ▲ 0.0% | 62 ▲ 18.4% | 62 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 166 | 166 ▲ 0.0% | 169 ▲ 1.7% | 169 ▲ 0.0% | 135 ▼ 19.7% | 135 ▲ 0.0% | 327 ▲ 141.1% | 327 ▲ 0.0% | 578 ▲ 77.1% | 578 ▲ 0.0% | 567 ▼ 2.0% | 567 ▲ 0.0% | 302 ▼ 46.8% | 302 ▲ 0.0% | 213 ▼ 29.3% | 213 ▲ 0.0% | 232 ▲ 9.0% | 232 ▲ 0.0% | |
53 | 53 ▲ 0.0% | 52 ▼ 2.1% | 52 ▲ 0.0% | 38 ▼ 26.3% | 38 ▲ 0.0% | 83 ▲ 118.8% | 83 ▲ 0.0% | 160 ▲ 93.0% | 160 ▲ 0.0% | 161 ▲ 0.5% | 161 ▲ 0.0% | 69 ▼ 57.0% | 69 ▲ 0.0% | 55 ▼ 21.1% | 55 ▲ 0.0% | 63 ▲ 15.9% | 63 ▲ 0.0% | ||
| Effective Tax %Derived | 31.76% | 31.76% | 30.56% | 30.56% | 28.04% | 28.04% | 25.44% | 25.44% | 27.73% | 27.73% | 28.43% | 28.43% | 22.97% | 22.97% | 25.62% | 25.62% | 27.24% | 27.24% | |
| Total Profit for Period | 113 | 113 ▲ 0.0% | 117 ▲ 3.5% | 117 ▲ 0.0% | 97 ▼ 16.8% | 97 ▲ 0.0% | 243 ▲ 149.8% | 243 ▲ 0.0% | 418 ▲ 71.6% | 418 ▲ 0.0% | 406 ▼ 2.9% | 406 ▲ 0.0% | 232 ▼ 42.7% | 232 ▲ 0.0% | 159 ▼ 31.7% | 159 ▲ 0.0% | 169 ▲ 6.7% | 169 ▲ 0.0% | |
| Less: Non-controlling Interests | — | — | — | — | -7 | -7 ▲ 0.0% | 5 ▲ 172.4% | 5 ▲ 0.0% | 49 ▲ 833.1% | 49 ▲ 0.0% | 80 ▲ 62.0% | 80 ▲ 0.0% | 27 ▼ 65.7% | 27 ▲ 0.0% | 1 ▼ 95.8% | 1 ▲ 0.0% | — ▼ 100.0% | — | |
| Net Profit (Owner's PAT)Derived | 113 | 113 ▲ 0.0% | 117 ▲ 3.5% | 117 ▲ 0.0% | 105 ▼ 10.5% | 105 ▲ 0.0% | 238 ▲ 127.3% | 238 ▲ 0.0% | 368 ▲ 54.7% | 368 ▲ 0.0% | 326 ▼ 11.6% | 326 ▲ 0.0% | 205 ▼ 37.1% | 205 ▲ 0.0% | 157 ▼ 23.1% | 157 ▲ 0.0% | 169 ▲ 7.4% | 169 ▲ 0.0% | |
| Net Profit Margin %Derived | 12.90% | 12.90% | 12.42% | 12.42% | 11.20% | 11.20% | 18.16% | 18.16% | 15.88% | 15.88% | 13.82% | 13.82% | 12.48% | 12.48% | 11.27% | 11.27% | 11.87% | 11.87% | |
| PAT Growth YoY %Derived | — | — | 3.50% | 3.50% | -10.50% | — | 127.29% | — | 54.67% | 54.67% | -11.64% | -11.64% | -37.07% | -37.07% | -23.14% | -23.14% | 7.45% | 7.45% | |
| Earnings Per Share (EPS ₹) | 34.92 | 34.92 ▲ 0.0% | 36.14 ▲ 3.5% | 36.14 ▲ 0.0% | 32.34 ▼ 10.5% | 32.34 ▲ 0.0% | 73.51 ▲ 127.3% | 73.51 ▲ 0.0% | 113.71 ▲ 54.7% | 113.71 ▲ 0.0% | 100.47 ▼ 11.6% | 100.47 ▲ 0.0% | 63.22 ▼ 37.1% | 63.22 ▲ 0.0% | 48.73 ▼ 22.9% | 48.73 ▲ 0.0% | 52.21 ▲ 7.1% | 52.21 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | — | — | — | — | — | — | — | — | — | — | -0 | -0 ▲ 0.0% | -5 ▼ 2012.1% | -5 ▲ 0.0% | 0 ▲ 109.5% | 0 ▲ 0.0% | -0 ▼ 137.0% | -0 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 715 | 715 ▲ 0.0% | 779 ▲ 8.9% | 779 ▲ 0.0% | 805 ▲ 3.4% | 805 ▲ 0.0% | 991 ▲ 23.0% | 991 ▲ 0.0% | 1,749 ▲ 76.5% | 1,749 ▲ 0.0% | 1,804 ▲ 3.1% | 1,804 ▲ 0.0% | 1,370 ▼ 24.1% | 1,370 ▲ 0.0% | 1,217 ▼ 11.1% | 1,217 ▲ 0.0% | 1,221 ▲ 0.3% | 1,221 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 52.56% | 52.56% | 57.37% | 57.37% | 53.22% | 53.22% | 46.96% | 46.96% | 55.01% | 55.01% | 53.55% | 53.55% | 55.82% | 55.82% | 54.70% | 54.70% | 56.92% | 56.92% | |
| Employee Cost % of RevenueDerived | 5.14% | 5.14% | 5.12% | 5.12% | 5.45% | 5.45% | 5.17% | 5.17% | 3.95% | 3.95% | 3.61% | 3.61% | 5.01% | 5.01% | 5.72% | 5.72% | 5.90% | 5.90% | |
| Other Cost % of RevenueDerived | 20.34% | 20.34% | 19.72% | 19.72% | 20.33% | 20.33% | 18.31% | 18.31% | 16.21% | 16.21% | 17.63% | 17.63% | 20.24% | 20.24% | 21.79% | 21.79% | 19.61% | 19.61% | |
| Interest Coverage (x)Derived | 18.82x | 18.82x | 13.35x | 13.35x | 6.47x | 6.47x | 18.52x | 18.52x | 34.39x | 34.39x | 47.07x | 47.07x | 43.21x | 43.21x | 49.68x | 49.68x | 38.93x | 38.93x |
BALAJI AMINES segment analysis : revenue and profit mix.
Disclosed business segments at BALAJI AMINES with their share of revenue and profit, switchable between consolidated and standalone reporting.
BALAJI AMINES discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for BALAJI AMINES.
Our AI distills the core fundamental drivers supporting BALAJI AMINES, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
BALAJI AMINES's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Fortress balance sheet with debt-to-equity 0.0006x, minimal financial leverage risk.
Operating margin 14.93% TTM demonstrates superior pricing power versus specialty chemical peers.
Net margin 11.73% TTM surpasses peer ATUL 10.81%, signaling better cost control.
Operating cash flow exceeds PAT, confirming high-quality earnings backed by real cash.
Diverse product portfolio across pharma, agrochemicals, paints mitigates sector cyclicality.
Key Risks.
Latest quarterly sales declined 7.28% YoY despite strong TTM growth momentum.
Latest quarterly PAT fell 7.65% YoY, signaling near-term profitability pressure.
ROE 7.86% and ROCE 8.12% lag peer averages, indicating capital efficiency concerns.
Stock P/E 39.84x trades significantly above peer median 28.34x, premium valuation.
Dividend yield 0.44% minimal, unattractive for income-focused investors.
Flip Conditions.
Valuation risk. a P/E above 38 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.29%.
BALAJI AMINES peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — BALAJI AMINES is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
BALAJI AMINES chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for BALAJI AMINES — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
BALAJI AMINES delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for BALAJI AMINES over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in BALAJI AMINES stood at 35.5% of traded volume, against a 20-day average of 34.3%.
BALAJI AMINES announcements: results, concalls, ratings, M&A.
Filings BALAJI AMINES sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
BALAJI AMINES files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 131 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Balaji Amines Limited has informed the Exchange about Certificate under Regulations 74(5) of SEBI (Depositories and Participants) Regulations, 2018…
General Updates
Balaji Amines Limited has informed the Exchange about Disclosure under Regulation 30(2) read with Regulation 30(6) of, and sub-para 20 of Para A of…
General Updates
Balaji Amines Limited has informed the Exchange about Disclosure under Regulation 30(2) read with Regulation 30(6) of, and sub-para 20 of Para A of…
Action(s) initiated or orders passed
Balaji Amines Limited has informed the Exchange about Disclosure under Regulation 30(2) read with Regulation 30(6) of, and sub-para 20 of Para A of…
Change in Management
Balaji Amines Limited has informed the Exchange about Intimation of Completion of Tenure of Mr. Rajendrakumar Mohanprasad Tapadiya, Independent…
Investor decks & rating reports.
BALAJI AMINES dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue BALAJI AMINES has declared, sequenced by announce and record date.
BALAJI AMINES corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
BALAJI AMINES insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in BALAJI AMINES as reported to SEBI — buying and selling signals from the people who know the business best.
BALAJI AMINES insider activity below tracks 3 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| SMT GADDAM SUSHILA RAJA REDDY FOUNDATION | Insider | 28 Mar 2025 | buy | +98.9 K | ₹11.94 Cr. | ₹1,207.15 |
| NOMULA SARITA | Insider | 18 Mar 2025 | buy | +98.9 K | ₹11.97 Cr. | ₹1,210.05 |
| Hemanth Reddy Gaddam | Insider | 12 Mar 2025 | buy | +98.9 K | ₹12.31 Cr. | ₹1,244.20 |
About BALAJI AMINES: business, sector, key facts.
What BALAJI AMINES does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
BALAJI AMINES operates in the Specialty Chemicals industry under the Chemicals sector, listed as NSE: BALAMINES, BSE: 530999.
Balaji Amines Limited (BAL) is a prominent Indian manufacturer and supplier of methylamines, ethylamines, and a diverse range of specialty chemicals and pharmaceutical excipients. The company's core business revolves around the production and distribution of these crucial chemical compounds, catering to a vast array of industries both domestically and internationally.
BAL's chemical segment is the primary driver of its revenue, focusing on a comprehensive portfolio of products. This includes various methylamines (monomethylamine, dimethylamine, trimethylamine) and ethylamines (monoethylamine, diethylamine, triethylamine), along with derivatives like dimethyl and diethyl amino ethanol. Beyond these foundational chemicals, BAL also produces a wide selection of specialty chemicals such as N-methyl pyrrolidone, morpholine, and others vital to various industrial processes. Furthermore, the company offers a range of pharma excipients, including poly vinyl pyrrolidone, which are essential components in pharmaceutical formulations.
The company's diverse customer base spans a broad spectrum of industries, demonstrating the versatility and importance of its chemical offerings. These industries include pharmaceuticals, agrochemicals, paints and resins, animal feed, oil and gas, rubber cleaning chemicals, dyes and textiles, pesticides and insecticides, water treatment chemicals, optical brighteners, corrosion inhibitors, cosmetics, explosives, and foundry chemicals. This widespread application highlights the strategic importance of BAL's products across various sectors.
In addition to its chemical manufacturing business, BAL operates a secondary segment focused on hospitality. This involves the management and operation of Balaji Sarovar Premiere, a hotel located in Solapur, Maharashtra. While this segment contributes to the company's overall operations, the primary focus and revenue generation remain firmly rooted in its chemical manufacturing and distribution activities.
BAL maintains a significant international presence, exporting its products to a diverse global clientele. Its export markets include the United States, the United Kingdom, Argentina, Latin America, Canada, Israel, Australia, Bangladesh, Germany, Italy, Egypt, South Africa, and other international destinations. This global reach underscores BAL's position as a key player in the international chemical supply chain.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AARTI INDUSTRIES (AARTIIND) Share PricePeer
- AARTISURF (AARTISURF) Share PricePeer
- ARCHEAN CHEMICAL IND (ACI) Share PricePeer
- AETHER INDUSTRIES (AETHER) Share PricePeer
- ALKALI (ALKALI) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about BALAJI AMINES (BALAMINES).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of BALAJI AMINES (BALAMINES)?
The current share price of BALAJI AMINES (BALAMINES) is ₹1,848.80. Today, the stock has declined by ₹10.00 (0.54%), trading in a range of ₹1,810.10 to ₹1,874.70. The stock opened at ₹1,870.80 with a trading volume of 77,621 shares.
02Is BALAJI AMINES stock a good investment for long-term?
BALAJI AMINES can be considered for long-term investment based on several factors. The company has a market capitalization of ₹5,990.94 Cr., P/E ratio of 29.22, ROE of 7.86%, and ROCE of 7.83%. The dividend yield stands at 0.59%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of BALAJI AMINES stock?
The 52-week high price of BALAJI AMINES (BALAMINES) is ₹2,629.80, while the 52-week low is ₹968.10. Currently trading at ₹1,848.80, the stock is 90.97% above its 52-week low and 29.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy BALAJI AMINES stock at the current price?
Whether to buy BALAJI AMINES stock at ₹1,848.80 depends on multiple factors. The stock is currently trading with a P/E ratio of 29.22 and P/B ratio of 3.03. Today's performance shows a loss of 0.54%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of BALAJI AMINES and when is the next dividend?
BALAJI AMINES offers a dividend yield of 0.59%, which means for every ₹100 invested at the current price of ₹1,848.80, you can expect to receive approximately ₹0.59 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of BALAJI AMINES?
BALAJI AMINES's key financial metrics include: P/E Ratio: 29.22, P/B Ratio: 3.03, ROE: 7.86%, ROCE: 7.83%, Dividend Yield: 0.59%, EPS: ₹63.28, Book Value: ₹610.00, and Debt-to-Equity: 0.06. The company's market cap stands at ₹5,990.94 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is BALAJI AMINES stock performing today in the market?
BALAJI AMINES stock opened at ₹1,870.80 and is currently trading at ₹1,848.80, showing a decline of ₹10.00 (0.54%). The intraday high is ₹1,874.70 and low is ₹1,810.10. The trading volume stands at 77,621 shares, indicating moderate market participation today.
08What is the P/E ratio of BALAJI AMINES and what does it indicate?
BALAJI AMINES has a Price-to-Earnings (P/E) ratio of 29.22, which means investors are willing to pay 29.22 for every ₹1 of earnings. With an EPS of ₹63.28, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about BALAJI AMINES (BALAMINES) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.